Key Insights

Highlights

Treatment Research

1 treatments under study, led by Braingate Neural Interface System

Related Conditions

Often studied with 8 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Recruiting2

Clinical Trials (2)

Showing 2 of 2 trials
NCT05724173Not ApplicableRecruitingPrimary

Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia

NCT06094205Not ApplicableRecruitingPrimary

Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)

Showing all 2 trials

Research Network

Common Treatments

  • Braingate Neural Interface System2

Active Sponsors

  • National Institute on Deafness and Other Communication Disorders (NIDCD)2
  • Leigh R. Hochberg, MD, PhD.2

Top Investigators

Related Conditions

  • Brain Stem Infarctions2
  • Dysarthria2
  • Tetraplegia2
  • Spinal Cord Injuries2
  • Muscular Dystrophies2

Activity Timeline